Please turn JavaScript on
header-image

Hospitalpharmacyeuropefeed

Follow Hospitalpharmacyeuropefeed's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.

You can even combine different feeds with the feed for Hospitalpharmacyeuropefeed.

Subscribing and unsubscribing is fast, easy and risk free.

The whole service is free of cost.

Hospitalpharmacyeuropefeed: Hospital Pharmacy Europe - Clinical News, Views & ResearchHospital Pharmacy Europe

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  3.56 / week

Message History

European Medicines Agency executive director Emer Cooke speaks to Gerry Hughes about the areas where hospital pharmacists can have the greatest synergy with the European medicines regulator and reflects on the regulatory structures in place to support that contribution and optimise patient care across the continent.

Set within the continuously evolv...

Read full story

Real-time feedback from a smart inhaler does not improve outcomes for children with uncontrolled asthma compared to those who do not receive this feedback, according to a Dutch randomised controlled trial.

The Improving Adherence by Guiding Inhalation via Electronic Monitoring (IMAGINE) study, href="https://pediatrics.jmir.org/2025/1/e78526" rel="noopener ugc nof...

Read full story

Umbilical cord-derived mesenchymal stromal cells (UC-MSCs) could provide clinical benefit and restore responsiveness to previously failed biologic therapies in patients with severe, refractory psoriasis, a new case series suggests.

Cytokine-targeted biologics have transformed the management of psoriasis, yet an increasing number of patients are href="https://hosp...

Read full story

People with eczema can bathe daily or weekly without worsening their symptoms, a new randomised controlled trial has suggests.

The findings, published in the British Journal of Dermatology, show no difference in symptoms bet...

Read full story

Severe asthma biologic injections, such as tezepelumab, offer a shift away from oral corticosteroids and a path to clinical remission for patients by targeting underlying inflammation. However, real-world evidence is essential in understanding effectiveness, safety and predictors of response to truly move towards precision medicine in the severe ...

Read full story